Search
- Oct 11, 2023
The CEO of eGenesis elaborates on today's Nature paper using pig kidneys for transplantation in NHPs
Mike Curtis explains how transplanted pig kidneys have shown durability (over two years) in some non-human primates.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A